i-Sens Inc.
The Realization of Technology to Improve Human Healthi-SENS has the vision of the realization of technology to improve human health.Through its cutting edge biosensor and electrochemistry technology, i-SENS develops, produces and distributes products in order to improve human health. Through its patent coverage and research power stemming from the work of Dr. Cha and Dr. Nam in the field of biosensor technology, i-SENS continuously develops and launches new and innovative products into the world market. Through Electrochemistry Technology, i-SENS Possesses Original Biosensor TechnologyFrom its start in 2000 in electrochemistry, i-SENS has successfully developed blood glucose monitoring systems, electrolyte and gas analyzers, and immunosensors and launched those products successfully in places from its home market in Korea to worldwide markets including the US, Japan, Europe and many others. i-SENS’s CareSens blood glucose monitoring system line, through its small sample size and quick test time, has been receiving recognition from its users for its high quality and ease-of-use. From the initial launch with CareSens I to its latest product CareSens N, which includes proprietary auto-coding technology, CareSens has been taking its place as one of the top products in the world. In 2009, i-SENS received the Frost & Sullivan “2009 Asia Pacific Excellence in Healthcare Award” for its proprietary auto-coding technology. i-SENS strives to keep its high quality products through its world class production facility and ever-growing export business.i-Smart 30, i-SENS’s electrolyte analyzer based on micro-sensor technology, is a step ahead of its competitors though its all-inclusive closed system cartridge, accuracy, and ease-of-use i-SENS continues to look to the future with its continued development of the its immunosensor and blood gas analyzer and looks to launch these revolutionary products in the near future.
Company Introduction
The Realization of Technology to Improve Human Health
i-SENS has the vision of the realization of technology to improve human health.
Through its cutting edge biosensor and electrochemistry technology, i-SENS develops, produces and distributes products in order to improve human health.
Through its patent coverage and research power stemming from the work of Dr. Cha and Dr. Nam in the field of biosensor technology, i-SENS continuously develops and launches new and innovative products into the world market.
Through Electrochemistry Technology, i-SENS Possesses Original Biosensor Technology
From its start in 2000 in electrochemistry, i-SENS has successfully developed blood glucose monitoring systems, electrolyte and gas analyzers, and immunosensors and launched those products successfully in places from its home market in Korea to worldwide markets including the US, Japan, Europe and many others.
i-SENS’s CareSens blood glucose monitoring system line, through its small sample size and quick test time, has been receiving recognition from its users for its high quality and ease-of-use. From the initial launch with CareSens I to its latest product CareSens N, which includes proprietary auto-coding technology, CareSens has been taking its place as one of the top products in the world. In 2009, i-SENS received the Frost & Sullivan “2009 Asia Pacific Excellence in Healthcare Award” for its proprietary auto-coding technology.
i-SENS strives to keep its high quality products through its world class production facility and ever-growing export business.
i-Smart 30, i-SENS’s electrolyte analyzer based on micro-sensor technology, is a step ahead of its competitors though its all-inclusive closed system cartridge, accuracy, and ease-of-use i-SENS continues to look to the future with its continued development of the its immunosensor and blood gas analyzer and looks to launch these revolutionary products in the near future.
Detailed Company Information
i-Sens Inc.
- Business Type Manufacturer
- Year Established 2000
- Location South Korea
- Main Markets
- Total Employees 0 People
- Homepage www.i-sens.com/
- President Geunsik Cha
- Phone +82-2-916-6191
- FAX +82-2-910-0688
- Address 27-34, Gwangun-ro, Nowon-gu, Seoul
-
Product Category
Beauty & Personal Care
Health & Medical > Medical Devices > Examination & Testing Instrument
Health & Medical > Medical Devices > Examination & Testing Instrument > Other Examination & Testing Instrumnet - Factory Information
Additional Introduction
Hello, I am Dr. Geun Sig Cha, CEO of i-SENS.
First of all, I would like to thank all of our customers and shareholders for visiting our website.
i-SENS, Inc., a company that started with six researchers in a small laboratory in May 2000, is continuously thriving to become a world class bio-company and now employs hundreds of people. I-SENS, Inc. has successfully developed and secured state-of-the-art technology while implementing production and quality control system through constant investment overcoming the hardships of difficult economic environment. In the meantime, i-SENS was also able to secure and train high quality personnel as well.
Over the last ten years, i-SENS, Inc. has entered the advanced markets such as the US, Europe and Japan by developing and manufacturing blood glucose monitoring system while operating a world class production line. i-SENS, Inc. has also focused into developing the next generation blood analyzers and immunosensor devices, etc... As a result, i-SENS’ technology has been recognized by obtaining certificates by the US FDA, European CE and Japanese Ministry of Health, Labor and Welfare and is showing promising potential in the world.
In order to fulfill i-SENS’ vision of “Realization of technology to safeguard healthy lifestyle,” i-SENS, Inc. will continue to secure and train high quality personnel while pursuing the development of “Core Technology”
In addition, since i-SENS’ growth and success is owed to the attention and passion of our customers and shareholders, everyone at i-SENS will relentlessly advance to be one of the most loved and respected company.
I ask all of our customers and shareholders for their continuous support.